US2022168216A1PendingUtilityA1
Topical compositions and methods of using the same
Est. expiryFeb 28, 2033(~6.6 yrs left)· nominal 20-yr term from priority
A61K 9/06A61K 33/00A61K 47/6923A61P 17/10A61K 47/12A61P 31/04A61K 9/0014A61K 47/32A61K 47/10A61P 17/00
74
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates generally to compositions and methods of using the same.
Claims
exact text as granted — not AI-modifiedThat which is claimed is:
1 . A method of treating acne vulgaris, the method comprising topically applying to the skin of a subject a composition comprising:
a first viscosity increasing agent; at least one polyhydric alcohol; at least one buffering agent; a second viscosity increasing agent; at least one organic solvent; at least one humectant; at least one water repellent; at least one active pharmaceutical ingredient; and water.
2 . The method of claim 1 , wherein the composition is buffered to a pH of about 3 to about 8.
3 . The method of claim 1 , wherein the at least one active pharmaceutical ingredient comprises a nitric oxide-releasing active pharmaceutical ingredient.
4 . The method of claim 3 , wherein the nitric oxide-releasing active pharmaceutical ingredient comprises a nitric oxide-releasing compound having a diazeniumdiolate functional group, optionally wherein the nitric oxide releasing compound comprises a NO-releasing co-condensed silica particle.
5 . The method of claim 4 , wherein the nitric oxide-releasing active pharmaceutical ingredient is present in the composition in an amount of about 0.5% to about 10% by weight of the composition.
6 . The method of claim 4 , wherein the composition stores and/or releases nitric oxide in an amount of about 0.05% to about 3% by weight of the composition.
7 . The method of claim 6 , wherein the one nitric oxide-releasing active pharmaceutical ingredient releases nitric oxide in an amount of at least about 50% over a period of time of about 3 hours or less after topical application of the composition to skin of a subject.
8 . The method of claim 1 , wherein the composition comprises a first composition in admixture with a second composition, the first composition comprising:
the at least one polyhydric alcohol in an amount of about 1% to about 30% by weight of the first composition; the at least one viscosity increasing agent in an amount of about 0.1% to about 5% by weight of the first composition; the at least one buffering agent in an amount of about 0.01% to about 2% by weight of the first composition; and water in an amount of about 70% to about 99% by weight of the first composition; and
the second composition comprising:
the second viscosity increasing agent in an amount of about 0.5% to about 30% by weight of the second composition;
at least one organic solvent in an amount of about 50% to about 90 by weight of the second composition;
at least one humectant in an amount of about 2% to about 20% by weight of the second composition; and
the at least one water repellent in an amount of about 0.5% to about 15% by weight of the second composition.
9 . The method of claim 1 , wherein the composition is cosmetically elegant.
10 . The method of claim 1 , wherein the method reduces P. acnes counts on the skin of the subject.
11 . The method of claim 10 , wherein P. acnes counts are reduced by about 10% or greater over a defined period of time.
12 . The method of claim 10 , wherein the reduction in P. acnes counts is within 12 weeks or less.
13 . A method of treating acne vulgaris, the method comprising:
providing an anhydrous topical gel comprising a nitric oxide-releasing active pharmaceutical ingredient; providing a hydrogel; combining the anhydrous topical gel comprising the nitric oxide-releasing active pharmaceutical ingredient and the hydrogel to provide a nitric oxide-releasing topical composition; and topically applying to the skin of a subject the nitric oxide-releasing topical composition.
14 . The method of claim 13 , wherein the nitric oxide-releasing topical composition is buffered to a pH of about 3 to about 8.
15 . The method of claim 13 , wherein the nitric oxide-releasing active pharmaceutical ingredient comprises a nitric oxide-releasing compound having a diazeniumdiolate functional group, optionally wherein the nitric oxide releasing compound comprises a NO-releasing co-condensed silica particle.
16 . The method of claim 13 , wherein the nitric oxide-releasing active pharmaceutical ingredient is present in the composition in an amount of about 0.5% to about 10% by weight of the composition.
17 . The method of claim 13 , wherein the nitric oxide-releasing topical composition stores and/or releases nitric oxide in an amount of about 0.05% to about 3% by weight of the composition.
18 . The method of claim 13 , wherein the nitric oxide-releasing active pharmaceutical ingredient releases nitric oxide in an amount of at least about 50% over a period of time of about 3 hours or less after topical application of the nitric oxide-releasing topical composition to skin of a subject.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.